Kite Pharma, Inc. Business Combination, Contingent Consideration, Liability, Current
Kite Pharma, Inc. had Business Combination, Contingent Consideration, Liability, Current of $16.62 million as of 2015-03-31, per its 10-Q filed 2015-05-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2015-05-15
- 2015-03-31: Business Combination, Contingent Consideration, Liability, Current $16.62M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2015-03-31 | $16.62M 10-Q · filed 2015-05-15 |